- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 1, 2026 | 42.81M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 43.08M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 42.95M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 40.82M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 40.84M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $29K |
| Capex | Q3 2026 · Mar 31, 2025 | $53K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$2.45M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$2.82M |
| Short Term Investments | Q3 2026 · Mar 31, 2026 | $7.93M |
| Short Term Investments | Q3 2026 · Jun 30, 2025 | $7.83M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $2.98M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $5M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $4.32M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $22.86M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $22.69M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $22.91M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $22.99M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $24.28M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $23.35M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $25.53M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $26.61M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $3.92M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $5.78M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $5.2M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $7.43M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $16.48M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $17.42M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $28.05M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $30.42M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.02 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.11 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.5M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $4.9M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $2.02M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $6.59M |
| Net Income | Q3 2026 · Mar 31, 2026 | $222K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$710K |
| Net Income | Q3 2026 · Dec 31, 2025 | −$576K |
| Net Income | Q3 2026 · Sep 30, 2025 | −$356K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$1.01M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$4.34M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$1.75M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$1.59M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$136K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$2.16M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$1.57M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$5.62M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $6.79M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $16.99M |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | $4.87M |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | $15.77M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $398K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.4M |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $648K |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $2.16M |
| Revenue | Q3 2026 · Mar 31, 2026 | $7.19M |
| Revenue | Q3 2026 · Mar 31, 2026 | $18.39M |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $5.52M |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $17.93M |